GlassScriptPhysician profile
Mario A Aragon
NPI 1073822664
$5,963.87
in general payments reported to CMS, 2019-2025
45 companies · $703 in 2025
The $703 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,591 · 2022: $1,274 · 2023: $1,374 · 2024: $1,023 · 2025: $703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,099.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $922.99 | 2021-2025 | |
| Novo Nordisk INC | $727.01 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $606.46 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Amgen INC. | $476.22 | 2021-2025 | Repatha, Otezla, Otezla |
| Esperion Therapeutics, INC. | $411.93 | 2021-2025 | Nexletol |
| Pfizer INC. | $355.35 | 2021-2025 | |
| Lilly USA, LLC | $328.27 | 2021-2025 | Mounjaro, Zepbound, Kisunla |
| Janssen Pharmaceuticals, INC | $264.78 | 2021-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $242.60 | 2021-2025 | Airsupra |
| Biohaven Pharmaceutical Holding Company LTD. | $158.27 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $113.16 | 2021 | |
| Glaxosmithkline, LLC. | $84.67 | 2021-2022 | |
| Genentech USA, INC. | $76.57 | 2021-2024 | Xolair |
| Idorsia Pharmaceuticals US INC | $76.51 | 2022-2024 | Quviviq |
| Edwards Lifesciences Corporation | $74.78 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Aragon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.